[251] R. Kroes, H. He, M. Emmett, C. Nilsson, F. Leach, I. Amster, A. Marshall, and J. Moskal. Overexpression <strong>of</strong> st6galnacv, a ganglioside-specific alpha 2, 6sialyltransferase, inhibits glioma growth in vivo. Proceedings <strong>of</strong> the National Academy <strong>of</strong> Sciences, 107(28):12646, 2010. [252] T. Kulikova, P. Aldebert, N. Althorpe, W. Baker, K. Bates, P. Browne, A. Van Den Broek, G. Cochrane, K. Duggan, R. Eberhardt, et al. The embl nucleotide sequence database. Nucleic Acids Research, 32(suppl 1):D27–D30, 2004. [253] M. Lafleur, D. Xu, and M. Hemler. Tetraspanin proteins regulate membrane type-1 matrix metalloproteinase-dependent pericellular proteolysis. Molecular Biology <strong>of</strong> the Cell, 20(7):2030–2040, 2009. [254] J. Lai, D. Sandhu, C. Yu, T. Han, C. Moser, K. Jackson, R. Guerrero, I. Aderca, H. Isomoto, M. Garrity-Park, et al. Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma. Hepatology, 47(4):1211–1222, 2008. [255] Y. Lam, E. di Tomaso, H.-K. Ng, J. Pang, M. Roussel, and N. Hjelm. Expression <strong>of</strong> p19 ink4d, cdk4, cdk6 in glioblastoma multiforme. British journal <strong>of</strong> neurosurgery, 14(1):28–32, 2000. [256] P. Landgraf, M. Rusu, R. Sheridan, A. Sewer, N. Iovino, A. Aravin, S. Pfeffer, A. Rice, A. Kamphorst, M. Landthaler, et al. A mammalian microrna expression atlas based on small rna library sequencing. Cell, 129(7):1401–1414, 2007. [257] B. Langmead, C. Trapnell, M. Pop, and S. Salzberg. Ultrafast and memory-efficient alignment <strong>of</strong> short dna sequences to the human genome. Genome Biol, 10(3):R25, 2009. [258] T. Lassmann, Y. Hayashizaki, and C. Daub. TagdustÂŮa program to eliminate artifacts from next generation sequencing data. Bioinformatics, 25(21):2839, 2009. [259] S. Lawler and E. Chiocca. Emerging functions <strong>of</strong> micrornas in glioblastoma. Journal <strong>of</strong> neuro-oncology, 92(3):297–306, 2009. [260] D. Lawson, M. Harrison, and C. Shapland. Fibroblast transgelin and smooth muscle sm22α are the same protein, the expression <strong>of</strong> which is down-regulated in many cell lines. Cell motility and the cytoskeleton, 38(3):250–257, 1998. [261] J. Lee, S. Kotliarova, Y. Kotliarov, A. Li, Q. Su, N. M. Donin, S. Pastorino, B. W. Purow, N. Christopher, W. Zhang, J. K. Park, and H. A. Fine. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype <strong>of</strong> primary tumors than do serum-cultured cell lines. Cancer Cell, 9(5):391–403, May 2006. [262] J. Lee, I. Vivanco, R. Beroukhim, J. Huang, W. Feng, R. DeBiasi, K. Yoshimoto, J. King, P. Nghiemphu, Y. Yuza, et al. Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain. PLoS medicine, 3(12):e485, 2006. [263] K. Lee, W. Han, J. Kim, I. Shin, E. Ko, I. Park, D. Lee, K. Oh, and D. Noh. The cd49d+/high subpopulation from isolated human breast sarcoma spheres possesses tumor-initiating ability. International journal <strong>of</strong> oncology, 40(3):665, 2012. [264] R. Lee, R. Feinbaum, and V. Ambros. The c. elegans heterochronic gene lin-4 encodes small rnas with antisense complementarity to lin-14. Cell, 75(5):843–854, 1993. [265] S. Lee, N. Syed, J. Taylor, P. Smith, B. Griffin, M. Baens, M. Bai, K. Bourantas, J. Stebbing, K. Naresh, et al. Dusp16 is an epigenetically regulated determinant <strong>of</strong> jnk signalling in burkitt’s lymphoma. British journal <strong>of</strong> cancer, 103(2):265–274, 2010. [266] Y. S. Lee, S. Pressman, A. P. Andress, K. Kim, J. L. White, J. J. Cassidy, X. Li, K. Lubell, H. Lim do, I. S. Cho, K. Nakahara, J. B. Preall, P. Bellare, E. J. Sontheimer, and R. W. Carthew. Silencing by small RNAs is linked to endosomal trafficking. Nat Cell Biol, 11(9):1150–6, 2009. [267] S. J. Leevers, B. Vanhaesebroeck, and M. D. Waterfield. Signalling through phosphoinositide 3-kinases: the lipids take centre stage. Current opinion in cell biology, 11(2):219–225, Apr. 1999.
[268] H. Lemjabbar-Alaoui, A. van Zante, M. Singer, Q. Xue, Y. Wang, D. Tsay, B. He, D. Jablons, and S. Rosen. Sulf-2, a heparan sulfate endosulfatase, promotes human lung carcinogenesis. Oncogene, 29(5):635–646, 2009. [269] G. Lemke. Glial control <strong>of</strong> neuronal development. Annual review <strong>of</strong> neuroscience, 24:87–105, 2001. [270] C. Leonetti, A. Biroccio, G. Graziani, and L. Tentori. Targeted therapy for brain tumours: Role <strong>of</strong> parp inhibitors. Current cancer drug targets, 12(3):218, 2012. [271] F. Leprêtre, C. Villenet, S. Quief, O. Nibourel, C. Jacquemin, X. Troussard, F. Jardin, F. Gibson, J. Kerckaert, C. Roumier, et al. Waved acgh: to smooth or not to smooth. Nucleic acids research, 38(7):e94–e94, 2010. [272] B. Lewis, C. Burge, and D. Bartel. Conserved seed pairing, <strong>of</strong>ten flanked by adenosines, indicates that thousands <strong>of</strong> human genes are microrna targets. Cell, 120(1):15–20, 2005. [273] B. P. Lewis, I. H. Shih, M. W. Jones-Rhoades, D. P. Bartel, and C. B. Burge. Prediction <strong>of</strong> mammalian microRNA targets. Cell, 115(7):787–98, 2003. [274] M. Lewis, S. Ross, P. Strickland, C. Snyder, and C. Daniel. Regulated expression patterns <strong>of</strong> irx-2, an iroquois-class homeobox gene, in the human breast. Cell and tissue research, 296(3):549–554, 1999. [275] A. Li, J. Walling, Y. Kotliarov, A. Center, M. E. Steed, S. J. Ahn, M. Rosenblum, T. Mikkelsen, J. C. Zenklusen, and H. A. Fine. Genomic changes and gene expression pr<strong>of</strong>iles reveal that established glioma cell lines are poorly representative <strong>of</strong> primary human gliomas. Molecular cancer research : MCR, 6(1):21–30, 2008. [276] M. Li, L. Pevny, R. Lovell-Badge, and A. Smith. Generation <strong>of</strong> purified neural precursors from embryonic stem cells by lineage selection. Current biology, 8(17):971–974, 1998. [277] Q. Li, A. Jedlicka, N. Ahuja, M. Gibbons, S. Baylin, P. Burger, J. Issa, et al. Concordant methylation <strong>of</strong> the er and n33 genes in glioblastoma multiforme. Oncogene, 16(24):3197, 1998. [278] Y. Li, F. Guessous, Y. Zhang, C. DiPierro, B. Kefas, E. Johnson, L. Marcinkiewicz, J. Jiang, Y. Yang, T. Schmittgen, et al. Microrna-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer research, 69(19):7569, 2009. [279] S. Liebner, C. Czupalla, and H. Wolburg. current concepts <strong>of</strong> blood-brain barrier development. The International journal <strong>of</strong> developmental biology, 2011. [280] A. Liekens, J. De Knijf, W. Daelemans, B. Goethals, P. De Rijk, and J. Del-Favero. Biograph: unsupervised biomedical knowledge discovery via automated hypothesis generation. Genome biology, 12(6):R57, 2011. [281] K. Ligon, J. Alberta, A. Kho, J. Weiss, M. Kwaan, C. Nutt, D. Louis, C. Stiles, and D. Rowitch. The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas. Journal <strong>of</strong> Neuropathology & Experimental Neurology, 63(5):499, 2004. [282] L. P. Lim, M. E. Glasner, S. Yekta, C. B. Burge, and D. P. Bartel. Vertebrate microRNA genes. Science, 299(5612):1540, 2003. [283] L. P. Lim, N. C. Lau, P. Garrett-Engele, A. Grimson, J. M. Schelter, J. Castle, D. P. Bartel, P. S. Linsley, and J. M. Johnson. Microarray analysis shows that some microRNAs downregulate large numbers <strong>of</strong> target mRNAs. Nature, 433(7027):769–73, 2005. [284] L. Linares, A. Hengstermann, A. Ciechanover, S. Müller, and M. Scheffner. Hdmx stimulates Hdm2-mediated ubiquitination and degradation <strong>of</strong> p53. Proceedings <strong>of</strong> the National Academy <strong>of</strong> Sciences, 100(21):12009, 2003. [285] A. Linkous, E. Yazlovitskaya, and D. Hallahan. Cytosolic phospholipase a2 and lysophospholipids in tumor angiogenesis. Journal <strong>of</strong> the National Cancer Institute, 102(18):1398–1412, 2010. [286] M. M. Lino and A. Merlo. PI3Kinase signaling in glioblastoma. Journal <strong>of</strong> neurooncology, 103(3):417–427, July 2011.
- Page 1 and 2:
Transcriptional Characterization of
- Page 3 and 4:
This dissertation is my own work an
- Page 5 and 6:
Acknowledgements I would like to th
- Page 7 and 8:
5.9 External Dataset Expression Cor
- Page 9 and 10:
Introduction 1
- Page 11 and 12:
1.1 Glial Cells in the Central Nerv
- Page 13 and 14:
1.2 Glioblastoma Multiforme Introdu
- Page 15 and 16:
1.2 Glioblastoma Multiforme Introdu
- Page 17 and 18:
1.2 Glioblastoma Multiforme Introdu
- Page 19 and 20:
1.3 Primary and Secondary Glioblast
- Page 21 and 22:
1.3 Primary and Secondary Glioblast
- Page 23 and 24:
1.3 Primary and Secondary Glioblast
- Page 25 and 26:
1.3 Primary and Secondary Glioblast
- Page 27 and 28:
1.3 Primary and Secondary Glioblast
- Page 29 and 30:
1.4 Pathways Involved in Glioblasto
- Page 31 and 32:
1.4 Pathways Involved in Glioblasto
- Page 33 and 34:
1.4 Pathways Involved in Glioblasto
- Page 35 and 36:
1.4 Pathways Involved in Glioblasto
- Page 37 and 38:
1.4 Pathways Involved in Glioblasto
- Page 39 and 40:
1.5 Pathway Crosstalk Introduction
- Page 41 and 42:
Chapter 2 Neurogenesis Contents 2.1
- Page 43 and 44:
2.1 Radial Glia Introduction VZ adj
- Page 45 and 46:
2.2 Neural Stem Cells Introduction
- Page 47 and 48:
2.2 Neural Stem Cells Introduction
- Page 49 and 50:
2.2 Neural Stem Cells Introduction
- Page 51 and 52:
2.2 Neural Stem Cells Introduction
- Page 53 and 54:
2.2 Neural Stem Cells Introduction
- Page 55 and 56:
2.2 Neural Stem Cells Introduction
- Page 57 and 58:
2.2 Neural Stem Cells Introduction
- Page 59 and 60:
2.2 Neural Stem Cells Introduction
- Page 61 and 62:
2.2 Neural Stem Cells Introduction
- Page 63 and 64:
2.2 Neural Stem Cells Introduction
- Page 65 and 66:
Chapter 3 Brain Cancer Stem Cells C
- Page 67 and 68:
3.1 The Cancer Stem Cell Hypothesis
- Page 69 and 70:
3.1 The Cancer Stem Cell Hypothesis
- Page 71 and 72:
3.2 Brain Cancer Stem Cells Introdu
- Page 73 and 74:
3.2 Brain Cancer Stem Cells Introdu
- Page 75 and 76:
3.2 Brain Cancer Stem Cells Introdu
- Page 77 and 78:
3.2 Brain Cancer Stem Cells Introdu
- Page 79 and 80:
3.2 Brain Cancer Stem Cells Introdu
- Page 81 and 82:
3.3 Glioma Culture Systems Introduc
- Page 83 and 84:
3.3 Glioma Culture Systems Introduc
- Page 85 and 86:
3.3 Glioma Culture Systems Introduc
- Page 87 and 88:
3.3 Glioma Culture Systems Introduc
- Page 89 and 90:
3.3 Glioma Culture Systems Introduc
- Page 91 and 92:
3.3 Glioma Culture Systems Introduc
- Page 93 and 94:
Chapter 4 The Non-Coding RNA World
- Page 95 and 96:
4.1 MicroRNA regulation Introductio
- Page 97 and 98:
4.1 MicroRNA regulation Introductio
- Page 99 and 100:
4.2 Target Prediction and Validatio
- Page 101 and 102:
Methods 93
- Page 103 and 104:
5.1 Tag-sequencing Data Processing
- Page 105 and 106:
5.1 Tag-sequencing Data Processing
- Page 107 and 108:
5.2 Array Comparative Genomic Hybri
- Page 109 and 110:
5.4 Quantitative Real Time-PCR Vali
- Page 111 and 112:
5.4 Quantitative Real Time-PCR Vali
- Page 113 and 114:
5.4 Quantitative Real Time-PCR Vali
- Page 115 and 116:
5.5 Literature Mining Methods Figur
- Page 117 and 118:
5.5 Literature Mining Methods How m
- Page 119 and 120:
5.6 Differential Isoform Expression
- Page 121 and 122:
5.9 External Dataset Expression Cor
- Page 123 and 124:
5.10 Glioblastoma Pathway Construct
- Page 125 and 126:
5.11 MicroRNA Target Prediction Ana
- Page 127 and 128:
Results 119
- Page 129 and 130:
6.2 Tag mapping Results Table 6.1:
- Page 131 and 132:
6.2 Tag mapping Results 123 Figure
- Page 133 and 134:
6.3 Copy Number Aberrations Results
- Page 135 and 136:
6.3 Copy Number Aberrations Results
- Page 137 and 138:
6.4 Core Differentially Expressed G
- Page 139 and 140:
6.4 Core Differentially Expressed G
- Page 141 and 142:
6.4 Core Differentially Expressed G
- Page 143 and 144:
6.4 Core Differentially Expressed G
- Page 145 and 146:
6.5 Large-scale qRT-PCR Validation
- Page 147 and 148:
6.5 Large-scale qRT-PCR Validation
- Page 149 and 150:
6.5 Large-scale qRT-PCR Validation
- Page 151 and 152:
6.6 Literature Mining for Different
- Page 153 and 154:
6.7 Isoform Differential Expression
- Page 155 and 156:
6.7 Isoform Differential Expression
- Page 157 and 158:
6.7 Isoform Differential Expression
- Page 159 and 160:
6.7 Isoform Differential Expression
- Page 161 and 162:
6.7 Isoform Differential Expression
- Page 163 and 164:
6.7 Isoform Differential Expression
- Page 165 and 166:
6.8 Long ncRNA Differential Express
- Page 167 and 168:
6.8 Long ncRNA Differential Express
- Page 169 and 170:
Chapter 7 Dataset Correlation Analy
- Page 171 and 172:
7.1 Enrichment Analysis Results Tab
- Page 173 and 174:
7.1 Enrichment Analysis Results Fig
- Page 175 and 176:
7.1 Enrichment Analysis Results Tab
- Page 177 and 178:
7.2 Glioblastoma Expression Signatu
- Page 179 and 180:
7.3 Tumour Expression Correlation R
- Page 181 and 182:
7.3 Tumour Expression Correlation R
- Page 183 and 184:
7.3 Tumour Expression Correlation R
- Page 185 and 186:
7.3 Tumour Expression Correlation R
- Page 187 and 188:
7.3 Tumour Expression Correlation R
- Page 189 and 190:
7.3 Tumour Expression Correlation R
- Page 191 and 192:
7.4 Survival Analysis Results Table
- Page 193 and 194:
7.4 Survival Analysis Results 867 g
- Page 195 and 196:
7.5 Glioblastoma Pathway Analysis R
- Page 197 and 198:
7.5 Glioblastoma Pathway Analysis R
- Page 199 and 200:
7.5 Glioblastoma Pathway Analysis R
- Page 201 and 202:
7.5 Glioblastoma Pathway Analysis R
- Page 203 and 204:
7.5 Glioblastoma Pathway Analysis R
- Page 205 and 206:
7.5 Glioblastoma Pathway Analysis R
- Page 207 and 208:
7.5 Glioblastoma Pathway Analysis R
- Page 209 and 210:
7.5 Glioblastoma Pathway Analysis R
- Page 211 and 212:
8.1 Principles Results say, this is
- Page 213 and 214:
8.3 Databases Results Figure 8.1: O
- Page 215 and 216:
8.3 Databases Results Figure 8.3: W
- Page 217 and 218:
8.4 Filters Results Bayesian method
- Page 219 and 220:
8.5 Target Prediction Ensemble Anal
- Page 221 and 222:
8.5 Target Prediction Ensemble Anal
- Page 223 and 224:
8.5 Target Prediction Ensemble Anal
- Page 225 and 226:
8.5 Target Prediction Ensemble Anal
- Page 227 and 228:
8.5 Target Prediction Ensemble Anal
- Page 229 and 230:
9.1. Digital Profiling of GNS Cell
- Page 231 and 232:
9.1. Digital Profiling of GNS Cell
- Page 233 and 234:
9.1. Digital Profiling of GNS Cell
- Page 235 and 236:
9.1. Digital Profiling of GNS Cell
- Page 237 and 238:
9.1. Digital Profiling of GNS Cell
- Page 239 and 240:
9.2. MicroRNA Target Prediction Ana
- Page 241 and 242:
9.3. Concluding Remarks Appendix pr
- Page 243 and 244:
A.1 Differential Expression Appendi
- Page 245 and 246:
A.1 Differential Expression Appendi
- Page 247 and 248:
A.1 Differential Expression Appendi
- Page 249 and 250:
A.1 Differential Expression Appendi
- Page 251 and 252:
A.1 Differential Expression Appendi
- Page 253 and 254:
A.1 Differential Expression Appendi
- Page 255 and 256:
A.1 Differential Expression Appendi
- Page 257 and 258:
A.1 Differential Expression Appendi
- Page 259 and 260:
A.2 Classified Differential Express
- Page 261 and 262:
A.2 Classified Differential Express
- Page 263 and 264:
A.2 Classified Differential Express
- Page 265 and 266:
A.3 Quantitative RT-PCR Appendix Ta
- Page 267 and 268:
A.3 Quantitative RT-PCR Appendix We
- Page 269 and 270:
A.3 Quantitative RT-PCR Appendix Ta
- Page 271 and 272:
A.3 Quantitative RT-PCR Appendix We
- Page 273 and 274:
A.4 Tag-seq vs qRT-PCR Correlation
- Page 275 and 276:
Appendix "BEX5", "DIAPH2", "GBP3",
- Page 277 and 278:
End Select End If End Sub Appendix
- Page 279 and 280:
If NameStr.ToLower().Equals("query"
- Page 281 and 282:
Appendix C Long ncRNAs We detected
- Page 283 and 284:
C. Long ncRNAs Appendix Tag Accessi
- Page 285 and 286: D.1 Pathway Interactions Appendix F
- Page 287 and 288: D.1 Pathway Interactions Appendix F
- Page 289 and 290: D.1 Pathway Interactions Appendix F
- Page 291 and 292: D.2 Pathway Images Appendix Figure
- Page 293 and 294: D.2 Pathway Images Appendix Figure
- Page 295 and 296: E. Exon Array Data Appendix Average
- Page 297 and 298: E. Exon Array Data Appendix Average
- Page 299 and 300: E. Exon Array Data Appendix Average
- Page 301 and 302: E. Exon Array Data Appendix Average
- Page 303 and 304: E. Exon Array Data Appendix Average
- Page 305 and 306: E. Exon Array Data Appendix Average
- Page 307 and 308: E. Exon Array Data Appendix Average
- Page 309 and 310: F. MicroRNA Array Data Appendix Tab
- Page 311 and 312: F. MicroRNA Array Data Appendix GNS
- Page 313 and 314: F. MicroRNA Array Data Appendix GNS
- Page 315 and 316: Ln Natural logarithm LOH Loss of He
- Page 317 and 318: 3.3 Schematisation of cell cycle ph
- Page 319 and 320: 8.3 Workflows at the core of the pr
- Page 321 and 322: 7.1 Selected Gene Ontology terms an
- Page 323 and 324: Bibliography [1] Cell signaling tec
- Page 325 and 326: [38] G. Bain, D. Kitchens, M. Yao,
- Page 327 and 328: [78] S. Bustin, V. Benes, J. Garson
- Page 329 and 330: [112] M. Czystowska, J. Han, M. Szc
- Page 331 and 332: [153] T. Fujiwara, M. Bandi, M. Nit
- Page 333 and 334: [192] M. Hernandez, M. Nieto, and M
- Page 335: [231] T.-M. Kim, W. Huang, R. Park,
- Page 339 and 340: [305] K. MAEDA, S. MATSUHASHI, K. T
- Page 341 and 342: [342] H. Moon, M. Ahn, J. Park, K.
- Page 343 and 344: [379] D. Park and J. Rich. Biology
- Page 345 and 346: [417] P. Rakic. Guidance of neurons
- Page 347 and 348: [456] T. Shima, N. Okumura, T. Taka
- Page 349 and 350: [490] P. A. C. t’Hoen, Y. Ariyure
- Page 351 and 352: [523] T. Watanabe, A. Takeda, T. Ts